FDA Section 4 \u2022 who must NOT take this
Nepafenac - Contraindications
These conditions, allergies, and situations mean Nepafenac should NOT be used. From the US FDA-approved drug label Section 4.
4 CONTRAINDICATIONS ILEVRO ® 0.3% is contraindicated in patients with previously demonstrated hypersensitivity to any of the ingredients in the formula or to other nonsteroidal anti-inflammatory drugs (NSAIDs).
Hypersensitivity to any of the ingredients in the formula or to other non-steroidal anti-inflammatory drugs (NSAIDS).